These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33893026)

  • 61. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

  • 62. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
    Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM
    J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
    PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A drug-related Good Samaritan Law and calling emergency medical services for drug overdoses in a Canadian setting.
    Moallef S; Choi J; Milloy MJ; DeBeck K; Kerr T; Hayashi K
    Harm Reduct J; 2021 Aug; 18(1):91. PubMed ID: 34446026
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework.
    Nguyen T; Buxton JA
    Int J Drug Policy; 2021 Jul; 93():103236. PubMed ID: 33838990
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
    Crowley D; Delargy I
    Harm Reduct J; 2020 Jul; 17(1):49. PubMed ID: 32680520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Living with Drug Use and Addiction during the COVID-19 Pandemic.
    Gage SH; Brewer G; Steen M; Lyons M
    Subst Use Misuse; 2022; 57(10):1504-1510. PubMed ID: 35787226
    [No Abstract]   [Full Text] [Related]  

  • 68. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
    Kolla G; Strike C
    Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
    Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
    Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness.
    Brothers TD; Leaman M; Bonn M; Lewer D; Atkinson J; Fraser J; Gillis A; Gniewek M; Hawker L; Hayman H; Jorna P; Martell D; O'Donnell T; Rivers-Bowerman H; Genge L
    Drug Alcohol Depend; 2022 Jun; 235():109440. PubMed ID: 35461084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
    Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
    Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.
    Levander XA; Hoffman KA; McIlveen JW; McCarty D; Terashima JP; Korthuis PT
    Addict Sci Clin Pract; 2021 Dec; 16(1):72. PubMed ID: 34895346
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impacts of COVID-19 on Youth Mental Health, Substance Use, and Well-being: A Rapid Survey of Clinical and Community Samples: Répercussions de la COVID-19 sur la santé mentale, l'utilisation de substances et le bien-être des adolescents : un sondage rapide d'échantillons cliniques et communautaires.
    Hawke LD; Barbic SP; Voineskos A; Szatmari P; Cleverley K; Hayes E; Relihan J; Daley M; Courtney D; Cheung A; Darnay K; Henderson JL
    Can J Psychiatry; 2020 Oct; 65(10):701-709. PubMed ID: 32662303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting.
    Bardwell G; Mansoor M; Van Zwietering A; Cleveland E; Snell D; Kerr T
    Harm Reduct J; 2022 Dec; 19(1):136. PubMed ID: 36476225
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence, Characteristics, and Management of Chronic Noncancer Pain Among People Who Use Drugs: A Cross-Sectional Study.
    Kaboré JL; Dassieu L; Roy É; Jutras-Aswad D; Bruneau J; Pagé MG; Choinière M
    Pain Med; 2020 Nov; 21(11):3205-3214. PubMed ID: 32869088
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.
    Friedman J; Bourgois P; Godvin M; Chavez A; Pacheco L; Segovia LA; Beletsky L; Arredondo J
    Int J Drug Policy; 2022 Jun; 104():103678. PubMed ID: 35421740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Challenges faced by people experiencing homelessness and their providers during the COVID-19 pandemic: a qualitative study.
    Hodwitz K; Parsons J; Juando-Pratts C; Rosenthal E; Craig-Neil A; Hwang SW; Lockwood J; Das P; Kiran T
    CMAJ Open; 2022; 10(3):E685-E691. PubMed ID: 35853663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.